ID Logo Medium PNG (Transparent Background).png
InterDigital Wins Two CSI Awards for Best Immersive Video and Video Processing Technology
September 16, 2024 08:30 ET | InterDigital, Inc.
InterDigital awarded CSI Awards for contributions to MPEG immersive standards and Advanced HDR solutions
logo.png
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
August 02, 2024 07:20 ET | Arch Biopartners
Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its unique...
AskBio receives FDA
AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease
July 11, 2024 08:00 ET | Asklepios BioPharmaceutical, Inc. (AskBio)
Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media  AB-1005 (formerly known as AAV2-GDNF) is being studied for the treatment of...
Lynch Carpenter Logo-01.png
Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
May 29, 2024 13:46 ET | Lynch Carpenter
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Cencora, Inc. recently announced that it suffered from a cybersecurity attack that occurred in February of 2024, which impacted the personal information...
AskBio Announces Nin
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
May 02, 2024 08:00 ET | Asklepios BioPharmaceutical, Inc. (AskBio)
Research Triangle Park, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG,...
AskBio receives FDA
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
April 18, 2024 08:00 ET | Asklepios BioPharmaceutical, Inc. (AskBio)
Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media AB-1002 is being studied for the treatment of adults with non-ischemic...
AskBio presents 18-m
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’s disease
April 16, 2024 08:03 ET | Asklepios BioPharmaceutical, Inc. (AskBio)
Berlin, Germany, and Research Triangle Park, NC, USA, April 16, 2024 (GLOBE NEWSWIRE) --   Not intended for UK Media AB-1005 (also known as AAV2-GDNF), an investigational gene therapy for the...
Mansuo Shannon, PhD
AskBio Names Mansuo Shannon Chief Scientific Officer
April 09, 2024 08:00 ET | Asklepios BioPharmaceutical, Inc. (AskBio)
Research Triangle Park, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and CompanyCo-Founder and former Chief...
Research Nester Logo.jpg
Drug Delivery Systems Market revenue to exceed USD 433 Billion by 2035, says Research Nester
March 18, 2024 05:00 ET | Research Nester
New York, March 18, 2024 (GLOBE NEWSWIRE) -- The global drug delivery systems market size is slated to expand at ~11% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 433...
cmi_logo.png
[Latest] Global Advanced Packaging Market Size/Share Worth USD 94.4 Billion by 2032 at a 10.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 22, 2024 11:30 ET | Custom Market Insights
Austin, TX, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Advanced Packaging Market Size, Trends and Insights By Type (Flip Chip CSP,...